Literature DB >> 30254073

Dimerization interface of osteoprotegerin revealed by hydrogen-deuterium exchange mass spectrometry.

Yiming Xiao1, Miaomiao Li2, Rinzhi Larocque2, Fuming Zhang3, Anju Malhotra3, Jianle Chen3, Robert J Linhardt3, Lars Konermann4, Ding Xu5.   

Abstract

Previous structural studies of osteoprotegerin (OPG), a crucial negative regulator of bone remodeling and osteoclastogenesis, were mostly limited to the N-terminal ligand-binding domains. It is now known that the three C-terminal domains of OPG also play essential roles in its function by mediating OPG dimerization, OPG-heparan sulfate (HS) interactions, and formation of the OPG-HS-receptor activator of nuclear factor κB ligand (RANKL) ternary complex. Employing hydrogen-deuterium exchange MS methods, here we investigated the structure of full-length OPG in complex with HS or RANKL in solution. Our data revealed two noteworthy aspects of the OPG structure. First, we found that the interconnection between the N- and C-terminal domains is much more rigid than previously thought, possibly because of hydrophobic interactions between the fourth cysteine-rich domain and the first death domain. Second, we observed that two hydrophobic clusters located in two separate C-terminal domains directly contribute to OPG dimerization, likely by forming a hydrophobic dimerization interface. Aided by site-directed mutagenesis, we further demonstrated that an intact dimerization interface is essential for the biological activity of OPG. Our study represents an important step toward deciphering the structure-function relationship of the full-length OPG protein.
© 2018 Xiao et al.

Entities:  

Keywords:  RANKL; bone loss; dimerization; heparan sulfate; heparin-binding protein; hydrogen exchange mass spectrometry; hydrogen-deuterium exchange; osteoclastogenesis; osteoporosis; osteoprotegerin

Mesh:

Substances:

Year:  2018        PMID: 30254073      PMCID: PMC6231129          DOI: 10.1074/jbc.RA118.004489

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Probing protein interactions with hydrogen/deuterium exchange and mass spectrometry-a review.

Authors:  Andrew J Percy; Martial Rey; Kyle M Burns; David C Schriemer
Journal:  Anal Chim Acta       Date:  2012-01-31       Impact factor: 6.558

2.  Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

Authors:  E Tsuda; M Goto; S Mochizuki; K Yano; F Kobayashi; T Morinaga; K Higashio
Journal:  Biochem Biophys Res Commun       Date:  1997-05-08       Impact factor: 3.575

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Increasing Fragmentation of Disulfide-Bonded Proteins for Top-Down Mass Spectrometry by Supercharging.

Authors:  Jiang Zhang; Rachel R Ogorzalek Loo; Joseph A Loo
Journal:  Int J Mass Spectrom       Date:  2015-02-01       Impact factor: 1.986

5.  Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.

Authors:  N Udagawa; N Takahashi; H Yasuda; A Mizuno; K Itoh; Y Ueno; T Shinki; M T Gillespie; T J Martin; K Higashio; T Suda
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

6.  A billion-fold range in acidity for the solvent-exposed amides of Pyrococcus furiosus rubredoxin.

Authors:  Janet S Anderson; Griselda Hernández; David M Lemaster
Journal:  Biochemistry       Date:  2008-05-15       Impact factor: 3.162

7.  Existence of a noncanonical state of iron-bound transferrin at endosomal pH revealed by hydrogen exchange and mass spectrometry.

Authors:  Cedric E Bobst; Mingxuan Zhang; Igor A Kaltashov
Journal:  J Mol Biol       Date:  2009-03-24       Impact factor: 5.469

8.  Visualization of arrestin recruitment by a G-protein-coupled receptor.

Authors:  Arun K Shukla; Gerwin H Westfield; Kunhong Xiao; Rosana I Reis; Li-Yin Huang; Prachi Tripathi-Shukla; Jiang Qian; Sheng Li; Adi Blanc; Austin N Oleskie; Anne M Dosey; Min Su; Cui-Rong Liang; Ling-Ling Gu; Jin-Ming Shan; Xin Chen; Rachel Hanna; Minjung Choi; Xiao Jie Yao; Bjoern U Klink; Alem W Kahsai; Sachdev S Sidhu; Shohei Koide; Pawel A Penczek; Anthony A Kossiakoff; Virgil L Woods; Brian K Kobilka; Georgios Skiniotis; Robert J Lefkowitz
Journal:  Nature       Date:  2014-06-22       Impact factor: 49.962

9.  Simultaneous reduction and digestion of proteins with disulfide bonds for hydrogen/deuterium exchange monitored by mass spectrometry.

Authors:  Hui-Min Zhang; Shaun M McLoughlin; Stephen D Frausto; Hengli Tang; Mark R Emmett; Alan G Marshall
Journal:  Anal Chem       Date:  2010-02-15       Impact factor: 6.986

10.  The Phyre2 web portal for protein modeling, prediction and analysis.

Authors:  Lawrence A Kelley; Stefans Mezulis; Christopher M Yates; Mark N Wass; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2015-05-07       Impact factor: 13.491

View more
  3 in total

1.  Antiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site.

Authors:  Miaomiao Li; Ding Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-07       Impact factor: 11.205

2.  Rank-Rankl-Opg Axis in Multiple Sclerosis: The Contribution of Placenta.

Authors:  Sofia Passaponti; Leonardo Ermini; Giulia Acconci; Filiberto Maria Severi; Roberta Romagnoli; Santina Cutrupi; Marinella Clerico; Gisella Guerrera; Francesca Ietta
Journal:  Cells       Date:  2022-04-15       Impact factor: 7.666

3.  Biochemical characterization of a disease-causing human osteoprotegerin variant.

Authors:  Yin Luo; Miaomiao Li; Ding Xu
Journal:  Sci Rep       Date:  2022-09-10       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.